<- Go Home
Sinobiopharma, Inc.
As of September 22, 2008, Sinobiopharma, Inc. was acquired by DongYing (Jiangsu) Pharmaceuticals Co., Ltd., in a reverse merger transaction. Sinobiopharma, Inc. focuses on the research, development, and production of biopharmaceuticals. The company is based in Nantong City, China.
Market Cap
$201.0M
Volume
350.4K
Cash and Equivalents
$2.0K
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$2.25
52 Week Low
$0.00
Dividend
N/A
Price / Book Value
-9.2K
Price / Earnings
-2.8K
Price / Tangible Book Value
-9.2K
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$70.8K
Return on Equity
N/A
Return on Assets
N/A
Cash and Short Term Investments
$2.0K
Debt
$8.7K
Equity
-$22.0K
Revenue
N/A
Unlevered FCF
N/A
Sector
Pharmaceuticals
Category
N/A